N. Tsavaris

453 total citations
38 papers, 324 citations indexed

About

N. Tsavaris is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Tsavaris has authored 38 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Tsavaris's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (10 papers) and Chemotherapy-induced organ toxicity mitigation (8 papers). N. Tsavaris is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (10 papers) and Chemotherapy-induced organ toxicity mitigation (8 papers). N. Tsavaris collaborates with scholars based in Greece, United States and France. N. Tsavaris's co-authors include P. Kosmidis, Christos Kosmas, N. Mylonakis, Ifigeneia Tzannou, N. Malamos, Constantin N. Baxevanis, Aristidis Polyzos, Maria Michelle Papamichael, L. Giannikos and George Fountzilas and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

N. Tsavaris

37 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Tsavaris Greece 10 196 85 70 63 48 38 324
C. De Gislain France 9 137 0.7× 141 1.7× 20 0.3× 116 1.8× 80 1.7× 15 441
R. Biamonte Italy 5 184 0.9× 47 0.6× 134 1.9× 104 1.7× 33 0.7× 8 370
Olaf Hansen Germany 8 160 0.8× 25 0.3× 140 2.0× 67 1.1× 64 1.3× 24 324
Jochem Potenberg Germany 11 229 1.2× 46 0.5× 41 0.6× 99 1.6× 35 0.7× 32 324
M Tomšová Czechia 7 251 1.3× 11 0.1× 46 0.7× 61 1.0× 22 0.5× 22 387
E Antoine France 7 294 1.5× 32 0.4× 31 0.4× 160 2.5× 53 1.1× 16 461
Olusola Olusesan Faluyi United Kingdom 11 163 0.8× 11 0.1× 50 0.7× 33 0.5× 46 1.0× 29 292
J Lokich United States 6 342 1.7× 58 0.7× 87 1.2× 98 1.6× 47 1.0× 7 414
Brian M.J. Cantwell United Kingdom 12 236 1.2× 22 0.3× 16 0.2× 83 1.3× 39 0.8× 21 369

Countries citing papers authored by N. Tsavaris

Since Specialization
Citations

This map shows the geographic impact of N. Tsavaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Tsavaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Tsavaris more than expected).

Fields of papers citing papers by N. Tsavaris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Tsavaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Tsavaris. The network helps show where N. Tsavaris may publish in the future.

Co-authorship network of co-authors of N. Tsavaris

This figure shows the co-authorship network connecting the top 25 collaborators of N. Tsavaris. A scholar is included among the top collaborators of N. Tsavaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Tsavaris. N. Tsavaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malagari, Katerina, Hippocrates Moschouris, Chrysovalantis Vergadis, et al.. (2023). Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30–60 μm Microspheres Loaded with Irinotecan. CardioVascular and Interventional Radiology. 46(7). 880–890. 2 indexed citations
2.
Kosmas, Christos, George Vorgias, Georgios Tsakonas, et al.. (2011). Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours. British Journal of Cancer. 105(7). 897–902. 2 indexed citations
3.
Kosmas, Christos, N. Mylonakis, Georgios Tsakonas, et al.. (2009). Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer. British Journal of Cancer. 101(7). 1059–1065. 24 indexed citations
4.
Kosmas, Christos, N. Tsavaris, N. Mylonakis, et al.. (2007). Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study. Journal of Chemotherapy. 19(3). 322–331. 3 indexed citations
5.
Leonardou, Polytimi, Paris Pappas, Dimitrios Filippou, et al.. (2005). Screening of patients after colectomy: virtual colonography. Abdominal Imaging. 31(5). 521–528. 5 indexed citations
6.
Kosmas, Christos, et al.. (2003). Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer. British Journal of Cancer. 88(8). 1168–1174. 7 indexed citations
7.
Sipsas, Nikolaos V., George Panayiotakopoulos, Athina Androulaki, et al.. (2002). Extranodal Non-Hodgkin Lymphoma Presenting as a Soft Tissue Mass in the Proximal Femur in a HIV(+) Patient. Leukemia & lymphoma. 43(12). 2405–2407. 6 indexed citations
9.
Tsavaris, N., D. Skarlos, Gerasimos Aravantinos, et al.. (2000). Combined Treatment with Low-Dose Interferon plus Vinblastine Is Associated with Less Toxicity Than Conventional Interferon Monotherapy in Patients with Metastatic Renal Cell Carcinoma. Journal of Interferon & Cytokine Research. 20(8). 685–690. 5 indexed citations
11.
Polyzos, Aristidis, N. Tsavaris, Christos Kosmas, et al.. (1999). Second-Line Chemotherapy with Cisplatin-Ifosfamide in Patients with Ovarian Cancer Previously Treated with Carboplatin-Cyclophosphamide. Journal of Chemotherapy. 11(2). 144–149. 7 indexed citations
12.
Tsavaris, N., Michalis Tzivras, Christos Kosmas, et al.. (1998). Combined Epirubicin, 5-Fluorouracil and Folinic Acid vs No Treatment for Patients with Advanced Pancreatic Cancer: A Prospective Comparative Study. Journal of Chemotherapy. 10(4). 331–337. 8 indexed citations
14.
Tsavaris, N., A. Polyzos, Christos Kosmas, J Gogas, & L. Giannikos. (1997). A feasibility study of 1-h paclitaxel infusion in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 40(4). 353–357. 15 indexed citations
15.
Tsavaris, N., et al.. (1996). 5-Fluorouracil, Epirubicin, and Mitomycin C Versus 5-Fluorouracil, Epirubicin, Mitomycin C, and Leucovorin in Advanced Gastric Carcinoma. American Journal of Clinical Oncology. 19(5). 517–521. 9 indexed citations
16.
Tsavaris, N., et al.. (1995). Efficacy of Ondansetron Treatment with Different Timing Schedules: A Randomized Double–Blind Study. Oncology. 52(4). 315–318. 1 indexed citations
17.
Tsavaris, N., et al.. (1992). Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemotherapy and Pharmacology. 30(4). 330–333. 40 indexed citations
19.
Tsavaris, N., et al.. (1990). Comparison of Antiemetic Activity of Chloropromazine and High Doses of Metoclopramide in Cisplatin-Based Chemotherapy. Acta Oncologica. 29(8). 1005–1009. 7 indexed citations
20.
Tsavaris, N., et al.. (1990). Conservative Approach to the Treatment of Chemotherapy‐Induced Extravasation. The Journal of Dermatologic Surgery and Oncology. 16(6). 519–522. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026